AGP Executive Report
Last update: 8 hours agoCancer Care: Onco360 will distribute pimicotinib for adults with symptomatic tenosynovial giant cell tumors when surgery could cause serious harm. In a trial, 56% of patients responded by week 25, compared with 3.2% on placebo. Obesity Treatment: A new JAMA report estimates one in nine U.S. adults takes a GLP-1 drug, but warns medication alone won’t address obesity’s wider challenges. The drugs also carry a warning about a rare, serious eye condition. Drug Safety: A popular blood pressure medication has been recalled nationwide over possible metal contamination. Medicaid: The federal government is offering states six more months before enforcing new work requirements, but Nebraska says it won’t take the delay, while Louisiana plans to seek it.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.